Mounjaro®
Starting from £179.99/mo
Start journey Learn moreThe short answer is: yes, you can take semaglutide at a time that suits you — including in the evening — but the guidance from the NHS medicines page for semaglutide is clear that timing is less important than consistency. Pick a day and time you can stick to week after week, and keep to it. That said, for the Wegovy tablet (oral semaglutide), bedtime is explicitly ruled out: it must be taken first thing in the morning on an empty stomach. These are prescription-only medicines and your prescriber decides which form is right for you, not the other way around.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
For the weekly semaglutide injection (Wegovy), the licensed guidance does not specify a required time of day. The NHS semaglutide medicine guide advises choosing any day and time that is convenient for you and repeating it each week. That predictability matters more than the clock. Evening or bedtime injections are not excluded, and if you are wondering whether you can take Wegovy before bed, many people find that a fixed routine built around something they already do each week (a Sunday evening ritual, for instance, or the same weekday after dinner) makes it easier to stay consistent across months of treatment.
What the guidance does not support is improvising. If your usual day falls on a bank holiday or you are travelling and want to shift by a day, you can, provided the gap between doses does not fall below 72 hours or exceed a missed-dose window. Specific guidance on what to do if you miss a dose is in your Patient Information Leaflet; those decisions sit with your prescriber, not a general article.
The practical upshot: bedtime injections are fine for the Wegovy pen. Whether evening suits you personally depends on your own side-effect pattern, which is worth discussing with our clinical team.
If you are asking about oral semaglutide (the Wegovy tablet approved by the MHRA on 11 June 2026) the answer changes entirely. The tablet uses an absorption enhancer called SNAC that only works properly under very specific conditions: an empty stomach, a small amount of plain water (up to around 120 ml), and then a wait of at least 30 minutes before any food, drink or other oral medicines. If you are weighing up whether it is ok to take Wegovy before bed, taking it at night would almost certainly mean taking it with food still in your system from the evening meal, which sharply reduces absorption. The tablet is designed around your morning routine, not your bedtime one.
This distinction matters because some readers searching this question may have recently switched from the injection to the Wegovy tablet, or may be wondering whether the tablet offers the same flexibility. It does not, on timing. In return it offers something the injection cannot: no refrigeration needed, no needles, and easy travel. The trade-off is a more rigid morning protocol.
More detail on the tablet form (its trial results, dosing schedule and how it compares to the injection) is covered on our semaglutide overview page.
This comes up often. The thinking is intuitive: if nausea tends to peak in the hours after a dose, taking the injection before sleep might mean you sleep through the worst of it. Some people do report finding this helpful. The honest position, though, is that there is no robust clinical trial evidence directly comparing morning versus evening injection and measuring side-effect burden, the STEP 1 trial in the New England Journal of Medicine, which reported around 15% average weight reduction over 68 weeks at the 2.4 mg maintenance dose, was not designed to answer that question.
What is well established is that nausea and other gastrointestinal effects are most common in the early weeks of treatment and after each dose increase, and they typically ease as the body adjusts. Staying well hydrated, eating smaller meals and avoiding fatty or very rich food around dose day are the steps most consistently supported by clinical guidance. If side effects remain disruptive after the first couple of weeks on a new dose, that is a conversation for your prescriber, not a timing tweak to manage alone.
For a fuller account of what to expect (and when symptoms warrant getting medical advice quickly) our weight-loss treatment guide covers the key safety points.
Timing preference is a reasonable thing to mention at your consultation, particularly if you work shifts, have young children, or know from experience that mornings are chaotic. A prescriber reviewing your case at nume will factor in your lifestyle alongside your clinical picture. For anyone on tirzepatide or considering switching between medicines, the question of timing and routine is part of the broader conversation about which treatment suits you, and our guide on how to dilute semaglutide is one of several practical resources available alongside the semaglutide options covered on our semaglutide guidance page.
One practical note: if your usual dose day tends to land on a Monday because that is when you started, ordering by noon on Monday is how you benefit from same-day dispatch. Some patients find it easier to pick a weekend day instead, which sidesteps the question entirely. Logistical details like that are easy to flag when you check your eligibility with our prescribers.
These are prescription-only medicines. Every decision about dose, timing and routine is confirmed by a GPhC-registered prescriber reviewing your individual case, not by a general timing rule.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.